Document Detail


Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.
MedLine Citation:
PMID:  14578311     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Over the past decade laboratories that test for metabolic disorders have introduced tandem mass spectrometry (MS/MS), which is more sensitive, specific, reliable, and comprehensive than traditional assays, into their newborn-screening programs. MS/MS is rapidly replacing these one-analysis, one-metabolite, one-disease classic screening techniques with a one-analysis, many-metabolites, many-diseases approach that also facilitates the ability to add new disorders to existing newborn-screening panels. METHODS: During the past few years experts have authored many valuable articles describing various approaches to newborn metabolic screening by MS/MS. We attempted to document key developments in the introduction and validation of MS/MS screening for metabolic disorders. Our approach used the perspective of the metabolite and which diseases may be present from its detection rather than a more traditional approach of describing a disease and noting which metabolites are increased when it is present. CONTENT: This review cites important historical developments in the introduction and validation of MS/MS screening for metabolic disorders. It also offers a basic technical understanding of MS/MS as it is applied to multianalyte metabolic screening and explains why MS/MS is well suited for analysis of amino acids and acylcarnitines in dried filter-paper blood specimens. It also describes amino acids and acylcarnitines as they are detected and measured by MS/MS and their significance to the identification of specific amino acid, fatty acid, and organic acid disorders. CONCLUSIONS: Multianalyte technologies such as MS/MS are suitable for newborn screening and other mass screening programs because they improve the detection of many diseases in the current screening panel while enabling expansion to disorders that are now recognized as important and need to be identified in pediatric medicine.
Authors:
Donald H Chace; Theodore A Kalas; Edwin W Naylor
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical chemistry     Volume:  49     ISSN:  0009-9147     ISO Abbreviation:  Clin. Chem.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-10-27     Completed Date:  2003-11-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1797-817     Citation Subset:  IM    
Affiliation:
Pediatrix Screening, PO Box 219, 90 Emerson Lane, Bridgeville, PA 15017, USA. donald_chace@pediatrix.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Metabolism, Inborn Errors / blood
Amino Acids / blood
Blood Specimen Collection*
Carnitine / analogs & derivatives*,  blood
Hematologic Tests / methods*
Humans
Infant, Newborn
Lipid Metabolism, Inborn Errors / blood
Mass Spectrometry / methods*
Chemical
Reg. No./Substance:
0/Amino Acids; 0/acylcarnitine; 541-15-1/Carnitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascula...
Next Document:  Critique of the Guide to the expression of uncertainty in measurement method of estimating and repor...